Discovery of Anticancer Agents from 2-Pyrazoline-Based Compounds.

Li, Qing-Shan; Shen, Bang-Nian; Zhang, Zhen; Luo, Shuying; Ruan, Ban-Feng

Li, Qing-Shan; Shen, Bang-Nian; Zhang, Zhen; Luo, Shuying; Ruan, Ban-Feng.

Afiliación

Li QS; School of Food and Biological Engineering, Key Laboratory of Metabolism and Regulation for Major Diseases of Anhui Higher Education Institutes, Hefei University of Technology, Hefei, 230601, China.
Shen BN; School of Food and Biological Engineering, Key Laboratory of Metabolism and Regulation for Major Diseases of Anhui Higher Education Institutes, Hefei University of Technology, Hefei, 230601, China.
Zhang Z; School of Food and Biological Engineering, Key Laboratory of Metabolism and Regulation for Major Diseases of Anhui Higher Education Institutes, Hefei University of Technology, Hefei, 230601, China.
Luo S; Henan Provincial Key Laboratory of Children's Genetics and Metabolic Diseases, Children's Hospital Affiliated to Zhengzhou University, Zhengzhou University, Zhengzhou, 450018, China.
Ruan BF; School of Food and Biological Engineering, Key Laboratory of Metabolism and Regulation for Major Diseases of Anhui Higher Education Institutes, Hefei University of Technology, Hefei, 230601, China.

Curr Med Chem ; 28(5): 940-962, 2021.

Article en En | MEDLINE | ID: mdl-32141413

Asunto(s)

Antineoplásicos; Antineoplásicos/farmacología; Humanos; Relación Estructura-Actividad

Palabras clave

2-pyrazoline; 4; 5-dihydro-1H-pyrazole; Nitrogencontaining heterocyclic structural units; SAR; anticancer activities; derivatives; synthesis

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Antineoplásicos Límite: Humans Idioma: En Revista: Curr Med Chem Asunto de la revista: QUIMICA Año: 2021 Tipo del documento: Article País de afiliación: China Pais de publicación: Emiratos Árabes Unidos

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google